Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
Ocular diseases cause visual impairment and blindness, imposing a devastating impact on quality of life and a substantial societal economic burden. Many such diseases lack universally effective pharmacotherapies. Therefore, understanding the mediators involved in their pathophysiology is necessary f...
Saved in:
Main Authors: | Bomina Park (Author), Timothy W. Corson (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases
by: Trupti Shetty, et al.
Published: (2020) -
Inhibition of Soluble Epoxide Hydrolase for Renal Health
by: Jun-Yan Liu, et al.
Published: (2019) -
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019) -
Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
Published: (2020) -
Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation
by: Brandes Ralf P, et al.
Published: (2011)